Glaukos has completed patient enrolment in its Phase II clinical trial evaluating GLK-321 for the treatment of Demodex blepharitis, using its iLution platform designed for dropless, transdermal drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results